홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Di-tert-butyl dicarbonate → HCID 68557056, 화합물

HRID 1869185
노트
인쇄 미리보기

반응식

HRID 1869185 반응식
CNCCC(C1C=CC=CC=1)C1C2C(=NC=CC=2)NC=1.CC(OC(OC(OC(C)(C)C)=O)=O)(C)C.[C:36]([O:40][C:41](=[O:62])[N:42]([CH3:61])[CH2:43][CH2:44][CH:45]([C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)[C:46]1[C:54]2[C:49](=[N:50][CH:51]=[CH:52][CH:53]=2)[NH:48][CH:47]=1)([CH3:39])([CH3:38])[CH3:37]>C(Cl)Cl>[C:36]([O:40][C:41](=[O:62])[N:42]([CH3:61])[CH2:43][CH2:44][C@H:45]([C:55]1[CH:56]=[CH:57][CH:58]=[CH:59][CH:60]=1)[C:46]1[C:54]2[C:49](=[N:50][CH:51]=[CH:52][CH:53]=2)[NH:48][CH:47]=1)([CH3:39])([CH3:38])[CH3:37]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 90495Di-tert-butyl dicarbonateHCID 16725756N-Methyl-[3-phenyl-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-propyl]amineHCID 68553855HCID 68553855, 화합물

생성물 1

HCID 68557056HCID 68557056, 화합물수율 31%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To a 0° C. solution of racemic methyl-[3-phenyl-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-propyl]-amine (267 mg, 1.01 mmol) in DCM (40 ml) was added TEA (0.47 ml, 3.37 mmol) followed by Boc2O (416 mg, 1.91 mmol). The mixture was warmed to RT over 1 hour, and then stirred at RT for 22 hours to give a racemic mixture of Methyl-[3-phenyl-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-propyl]-carbamic acid tert-butyl ester (not isolated). The reaction mixture was concentrated under reduced pressure, and purified via chiral preparative HPLC by multiple injections onto Chiralpak AD preparative 250×20 mm (hexane/i-PrOH, 6 ml/min), affording (R)-Methyl-[3-phenyl-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-propyl]-carbamic acid tert-butyl ester (215 mg, 31% yield) as a first fraction and (S)-Methyl-[3-phenyl-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-propyl]-carbamic acid tert-butyl estere (197 mg, 28% yield) as a second fraction.

후처리

  1. customto give
  2. customisolated)
  3. concentrationThe reaction mixture was concentrated under reduced pressure
  4. custompurified via chiral preparative HPLC by multiple injections onto Chiralpak AD preparative 250×20 mm (hexane/i-PrOH, 6 ml/min)

출처 및 근거

ORD 기록
ord-13adc5129e0e43579468efebf4e1c721
출처 데이터셋
uspto-grants-2009_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07638517B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트